Ann: Imugene appoints experienced life sciences CFO Mike Tonroe, page-72

Hi O&E

Totally agree, the CFO role is 'unique' (and very important) in most companies, both big and small. The stage that IMU is now at, with so many irons in the fire, has outgrown the 'outsourcing' of this role.

As I mentioned in an earlier post ... "personally, I would want a financial 'hard head' (my words) to be front and centre during deal negotiations with Big Pharma." I certainly stick by this. I would expect that the CFO will take on many tasks, but in the case of IMU, a major focus will be the negotiations, checking and management of 'deals' with big pharma. This is the phase (I believe) that IMU is racing towards, and the first 'deal' announcements may arrive much sooner than many think. This is a very exciting time and looks to be reflected in a rising share price.

What an amazing team PH and LC have built! Here we go ...